A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic Approach

This study has been terminated.

(Vaccine unavailable.)

Sponsor:

Information provided by (Responsible Party):

M.D. Anderson Cancer Center

ClinicalTrials.gov Identifier:

NCT00038415

First received: May 30, 2002

Last updated: August 1, 2012

Last verified: August 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	January 2005
Primary Completion Date:	July 2004 (Final data collection date for primary outcome measure)